# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on dev...
As of 12:01 a.m. on October 21, 2025, Genprex, Inc., a Delaware corporation (the "Company"), effected the previously di...